Patents by Inventor Fu Ou-Yang

Fu Ou-Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting proteins to deliver therapeutic or diagnostic reagents
    Patent number: 7906628
    Abstract: The present invention is directed to compositions comprising an angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a specific embodiment, the composition is a fusion gene or fusion gene product encoding the angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a particular embodiment, the composition is used for methods to treat angiogenesis-related diseases, such as cancer.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: March 15, 2011
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Mien-Chie Hung, Keng-Li Lan, Keng-Hsin Lan, Jaw-Ching Liu, Fu Ou Yang
  • Targeting proteins to deliver therapeutic or diagnostic reagents
    Patent number: 7893033
    Abstract: The present invention is directed to compositions comprising an angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a specific embodiment, the composition is a fusion gene or fusion gene product encoding the angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a particular embodiment, the composition is used for methods to treat angiogenesis-related diseases, such as cancer.
    Type: Grant
    Filed: May 6, 2003
    Date of Patent: February 22, 2011
    Assignee: Board of Regents, The University of Texas System
    Inventors: Mien-Chie Hung, Keng-Li Lan, Keng-Hsin Lan, Jaw-Ching Liu, Fu Ou-Yang
  • TARGETING PROTEINS TO DELIVER THERAPEUTIC OR DIAGNOSTIC REAGENTS
    Publication number: 20070134206
    Abstract: The present invention is directed to compositions comprising an angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a specific embodiment, the composition is a fusion gene or fusion gene product encoding the angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a particular embodiment, the composition is used for methods to treat angiogenesis-related diseases, such as cancer.
    Type: Application
    Filed: February 8, 2007
    Publication date: June 14, 2007
    Applicant: Board of Regents, University of Texas System
    Inventors: Mien-Chie Hung, Keng-Li Lan, Keng-Hsin Lan, Jaw-Ching Liu, Fu Ou-Yang
  • Targeting proteins to deliver therapeutic or diagnostic reagents
    Publication number: 20040005684
    Abstract: The present invention is directed to compositions comprising an angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a specific embodiment, the composition is a fusion gene or fusion gene product encoding the angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a particular embodiment, the composition is used for methods to treat angiogenesis-related diseases, such as cancer.
    Type: Application
    Filed: May 6, 2003
    Publication date: January 8, 2004
    Applicant: Board of Regents, The University of Texas System
    Inventors: Mien-Chie Hung, Keng-Li Lan, Keng-Hsin Lan, Jaw-Ching Liu, Fu Ou-Yang